Human Immunodeficiency Virus (HIV) Diagnosis Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Human Immunodeficiency Virus (HIV) Diagnosis Market?
The market size for diagnosing the human immunodeficiency virus (HIV) has expanded significantly in the past few years. The growth is expected to increase from $4.2 billion in 2024 to $4.68 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The historic period's growth is largely due to the growth of voluntary counseling and testing, the development of HIV antibody tests, the outbreak of the HIV/AIDS epidemic, and initiatives led by communities and peers.

The market size of the diagnosis for human immunodeficiency virus (HIV) is predicted to witness significant expansion in the coming years. It is forecasted to grow to a value of $7.12 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%. The projected growth within this period can be linked to the implementation of public health campaigns and awareness drives, an emphasis on equity and inclusivity, routine screenings in medical environments, community-led and peer-led methodologies, as well as the enlargement of self-testing. Notable developments expected within this period include progress in testing technologies, concentration on specific testing methodologies, community-based testing and outreach, a stress on equity and inclusivity, along with policy and funding preferences.

What Are the Primary Growth Drivers for the Human Immunodeficiency Virus (HIV) Diagnosis Market?
The HIV diagnosis market is projected to grow due to the increasing blood donations. Blood donation, a voluntary act of blood collection through phlebotomy - the process of inserting a needle into a vein for blood collection - is on the rise. The higher rate of blood donations, along with advancements in medical technology, participation from the community, and better strategies for recruitment and retention of donors, have contributed to this growth. As more individuals donate blood, a larger set of samples is available for HIV testing. This broad range of blood samples permits a more extensive screening for HIV antibodies or antigens, thereby enhancing the accuracy and dependability of HIV diagnosis. For example, the UK government agency NHS Blood and Transplant registered an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Hence, the increasing trend in blood donation is contributing to the expansion of the HIV diagnosis market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

Which Businesses Are at the Forefront of Human Immunodeficiency Virus (HIV) Diagnosis Market Development?
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

What Are the Latest Innovations in the Human Immunodeficiency Virus (HIV) Diagnosis Market?
Notable businesses in the HIV diagnosis market are advancing chip-based real-time PCR testing options for HIV to heighten precision, lessen processing time, and increase accessibility. these testing options for HIV function using microfluidic chips, or compact integrated circuits, to carry out real-time PCR tests that can identify HIV. For example, in August 2022, Molbio Diagnostics, a molecular diagnostics producer based in India, introduced the Truenat HIV-1 test. This chip-based real-time PCR test allows for the numeric detection and diagnosis of HIV-1 in blood and plasma samples. The function of this test is to assist in tracking an HIV-1 patient's viral load. It utilizes Taqman chemistry, and it's noted for significant primer sensitivity and specificity. The test only requires a small sample volume of 6 mcL and is equipped with an intelligent chip that comes with a lot-specific data that aids in quantifying results. Moreover, the test has a chip re-use lock and a reaction port specifically designed to resist contamination and evaporation.

How Is the Human Immunodeficiency Virus (HIV) Diagnosis Market Segmented?
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented -

1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Where Is the Human Immunodeficiency Virus (HIV) Diagnosis Market Growth Most Prominent?
North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report?

- Market Size Analysis: Analyze the Human Immunodeficiency Virus (HIV) Diagnosis Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Human Immunodeficiency Virus (HIV) Diagnosis Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Human Immunodeficiency Virus (HIV) Diagnosis Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Human Immunodeficiency Virus (HIV) Diagnosis Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15587

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.